Katie Twigger

A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

Laura Vidal, Hardev Pandha, Timothy A. Yap et al. · Clinical Cancer Research · 2008 · 239 citations

Life Sciences, Immunology, Oncology +17

Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

Eleni Karapanagiotou, Victoria Roulstone, Katie Twigger et al. · Clinical Cancer Research · 2012 · 187 citations · Full text

Medicine, Oncology, Pharmacology +15

Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus

Jian Qiao, Hongxun Wang, Timothy Kottke et al. · Clinical Cancer Research · 2008 · 176 citations · Full text

Medicine, Oncology, Pharmacology +16

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

Charles L. White, Katie Twigger, Laura Vidal et al. · Gene Therapy · 2008 · 151 citations

Life Sciences, Immunology, Oncology +16

REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer

Charles Comins, James Spicer, Andrew Protheroe et al. · Clinical Cancer Research · 2010 · 138 citations · Full text

Pharmacy, Pharmacology, Cancer Drug Toxicity Management +12